Related Experiment Video
Updated: Dec 31, 2025
15:04
A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
Published on: May 5, 2009
25.7K
Neuron-based high-content assay and screen for CNS active mitotherapeutics.
Boglarka H Varkuti1, Miklos Kepiro1, Ze Liu1
1Department of Neuroscience, The Scripps Research Institute, Jupiter, FL 33458, USA.
Science Advances
|January 15, 2020
Summary
Researchers developed a new screening method to find drugs that improve mitochondrial health in neurons. This led to the discovery of 67 small molecules, including one potent compound, that show promise as future neurological therapeutics.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Mitochondrial dysfunction is implicated in neurological and psychiatric disorders.
- Direct screening for neuronal mitotherapeutics is lacking.
Purpose of the Study:
- To develop a screening platform for neuronal mitostasis.
- To identify small molecules that modulate mitochondrial dynamics and function in neurons.
Main Methods:
- Developed a multiplexed, high-content screening assay using primary neurons.
- Identified 67 small-molecule modulators of neuronal mitostasis (MnMs).
- Assessed MnM effects on mitochondrial content, length, function, neurite outgrowth, and protection against neurotoxins.
Main Results:
- Most identified MnMs enhanced mitochondrial health and function without affecting neurite outgrowth.
- A subset of MnMs protected neurons from Aβ(1-42), glutamate, and oxidative stress.
- The top MnM improved synaptic activity and in vivo brain mitochondrial respiration.
Conclusions:
- The developed platform directly assesses neuronal mitostasis.
- Identified novel small-molecule modulators of mitochondrial dynamics and function.
- Discovered candidate molecules for developing mitotherapeutics for neurological disorders.
